UK funding for stroke and dementia research still too low, study says

Sums spent on conditions bear little relation to their costs to health services, as compared with cancer or heart disease, say researchers Research funding into stroke and dementia in the UK is still too low despite recent significant rises in state support, a study says. While the gap between budgets for these two conditions and cancer and coronary heart disease (CHD) has narrowed in terms of …

Two Cell Press journals review relationship between immune system and cancer

( Cell Press ) In a joint special issue on cancer, immunity, and immunotherapy, Cancer Cell and Trends in Immunology explore the history of this work and review how immunology and cancer research currently intersect. Articles explore drugs that eliminate cancer's hold on the immune system, as well as the ways the immune response is affected by anti-cancer therapies and vice versa.

Melanoma's 'safe haven' targeted for shut-down

( Cancer Research UK ) Melanoma cells become drug resistant by using surrounding healthy cells to provide a 'safe haven' from treatment, according to new research published in Cancer Cell on April 13, 2015.

Researchers identify drug target for ATRA, the first precision cancer therapy

( Beth Israel Deaconess Medical Center ) Cancerous tumors have the unique ability to activate alternative pathways to evade targeted therapy. They also contain cancer stem cells that can make them more aggressive and drug-resistant. Now researchers in the Cancer Research Institute at Beth Israel Deaconess Medical Center have identified a drug target that can address both of these challenges in …

Dogs Can Literally Sniff Out Prostate Cancer With Over 97% Accuracy, Study Finds

Dogs really are man's best friend – especially when it comes to sniffing out potentially lethal cancers , a new study has found. Research suggests that dogs can detect prostate cancer in roughly 98% of cases, simply through sniffing a man's urine. The findings have been hailed as "spectacular" by the co-founder of charity Medical Detection Dogs . The study, which was conducted by the Department …

Cerulean Announces Publication Showing CRLX101 Targets Breast Cancer Stem Cells and Impedes Resistance to Anti …

Cerulean Pharma Inc. , a leader in Dynamic Tumor Targeting™, today announced the publication of a manuscript in Breast Cancer Research and Treatment, describing precli